Abstract:HepatoBiliary Surg Nutr 2020;9(6):794-796 | http://dx.doi.org/10.21037/hbsn.2020.03.24 Liver cancer was ranked the sixth most commonly diagnosed cancer with the fourth leading cause of cancer-related deaths worldwide in 2018 (1). Notably, hepatocellular carcinoma (HCC) constitutes 75–85% among all the liver cancer cases, and ranks first morbidity and mortality of malignancies in Chinese males under 60. Due to hypervascularity in liver and high heterogeneity, HCC was regarded as an aggressive disease. Recent clinical trials focusing on resection and transplantation after targeted therapy for advanced HCC show encouraging results. However, the adjuvant therapy for patients with high risk of recurrence after surgery still raises attention. Currently, emerging evidence suggested that the crosstalk between tumor cells and the microenvironment plays a pivotal role in tumorigenesis and metastasis. The tumor microenvironment of HCC provides tumor cells with necessary conditions for their sustained growth, invasion and metastasis. It is typically characterized by dysregulated immune network, sustained injury and regeneration, angiogenesis, inflammation and metabolic reprogramming. These aforementioned characteristics raise attention to the important role of infiltrating immune cell profile and tumor stroma in microenvironmental regulation. According to the immune cell subset and proportion, HCC could be classified into different immune subtypes, for example, Sia’s “immune class/ exclusion” and Kurebayashi’s “immune high/mid/low”. Zhang et al. further identified three novel distinctive HCC subtypes with immunocompetent, immunodeficient, and immunosuppressive features (2). Immunocompetent and immunosuppressive subtype were characterized by robust immune cell infiltration and upregulated immune checkpoint molecules. These two subtypes, as well as the “immune class” and “immune-high subtype”, displayed significant increase in immune cells infiltration and better responsiveness to immunotherapy. Tumor stroma and vasculature could also cause considerable impact on tumor progression. Cancer-associated fibroblasts (CAFs) can result in a robust stromal reaction characterized by fibrotic extracellular matrix and make tumor cells convert to aggressive and immune-excluded phenotype via transforming growth factor-β (TGF-β) signaling pathway (3). Tumor-associated vasculature is another main hallmark of cancers. Endothelial cells (ECs) of the tumor vasculature can not only inhibit anti-tumor immunity by immune cells regulation and elimination, but also help to create a proangiogenic microenvironment via vascular endothelial growth factor (VEGF) signaling pathway (4). The disorganized tumor vasculature could remodel a special microenvironment characterized by hypoxia, acidosis, and high interstitial pressure, which both support tumor cells proliferation and structure a physical barrier for infiltrating immune cells (5). Furthermore, the interaction between different components relies on the regulation of chemokines and cytokines, which play essential roles in recruiting immune cells and maintaining cancer and stromal cell biology (6). In another word, these microenvironmental populations profoundly influence the tumor immune and metabolic homeostasis, which suggests immunometabolism as a novel perspective of HCC microenvironment. Editorial

Hepatocellular Carcinoma Cells Deteriorate the Biophysical Properties of Dendritic Cells

Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma

Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton.

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.

Infiltrating Regulatory T Cells Promote Invasiveness of Liver Cancer Cells Via Inducing Epithelial-Mesenchymal Transition

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments

Impaired function of dendritic cells within the tumor microenvironment

Ovarian Carcinoma Cells Effectively Inhibit Differentiation and Maturation of Dendritic Cells Derived from Hematopoietic Progenitor Cells in Vitro

Biophysical Properties And Motility Of Human Mature Dendritic Cells Deteriorated By Vascular Endothelial Growth Factor Through Cytoskeleton Remodeling

The Anti-Tumor Activity of Dendritic Cell/cytotoxic T Lymphocyte Induced by Cholangiocarcinoma-Derived Exosome and Its Ultrafiltered Lysate

[Changes in the Immune Function of Dendritic Cells (DC) Derived from HBV-related Hepatocellular Carcinoma (HCC) Patient's Peripheral Blood Monocytes (PBMC) Pulsed with Tumor Antigen].

Disturbance of Differentiation and Maturation of Dendritic Cells and Tumor Escape

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy

Effect of Dendritic Cell-Based Immunotherapy on Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Alterations of Dendritic Cell Subsets in the Peripheral Circulation of Patients with Cervical Carcinoma.

Down-regulation of Β-Centractin Might Be Involved in Dendritic Cells Dysfunction and Subsequent Hepatocellular Carcinoma Immune Escape: a Proteomic Study

[Relation Between Changes of Dendritic Cell Function and Down-Regulation of Beta-Centractin in Hepatocellular Carcinoma].

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Biomechanical Alterations of Dendritic Cells by Co-Culturing with K562 CML Cells and Their Potential Role in Immune Escape.

Effect of BCL9/BCL9L Inhibition–derived Th1 Cells on Dendritic Cells–mediated Antigen Presentation in Hepatocellular Carcinoma and on the Efficacy of CAR-T Immunotherapy.